Clinical Trials Directory

Trials / Completed

CompletedNCT01322295

Human Bronchial Microdialysis in Open Aortic Aneurysm Repair

Status
Completed
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Elective open aortic aneurysm repair has an overall reported 30 day mortality of 2-6 percent, but in patients more than 65-70 years the mortality is reported to be more than 10 percent. The phenomenon of acute lung injury (ALI)/adult respiratory distress syndrome (ARDS) after infra renal abdominal aneurysm repair caused by ischemia-reperfusion is well established. The degree of disability varies from a light degree of acute respiratory failure to mortality for patients with the same profile of risk. Primary aim is to develop a model that monitors inflammatory marker molecules collected from the bronchial epithelial lining fluid by microdialysis. The method with examination of the bronchial epithelial lining fluid by microdialysis and analysis of multiple inflammation markers as previously done by the investigators group.

Conditions

Timeline

Start date
2011-03-01
Primary completion
2011-11-01
Completion
2011-12-01
First posted
2011-03-24
Last updated
2017-09-21

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT01322295. Inclusion in this directory is not an endorsement.

Human Bronchial Microdialysis in Open Aortic Aneurysm Repair (NCT01322295) · Clinical Trials Directory